➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: October 27, 2021

DrugPatentWatch Database Preview

Generic Companies with Tentative Approvals for: dabigatran etexilate mesylate

Email this page to a colleague

« Back to Dashboard

dabigatran etexilate mesylate Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Generic Name	NDA	Strength	Dosage Form
Glenmark Pharms Ltd	dabigatran etexilate mesylate	207984	EQ 75MG BASE	CAPSULE;ORAL
Teva Pharms Usa	dabigatran etexilate mesylate	208057	EQ 110MG BASE	CAPSULE;ORAL
Alkem Labs Ltd	dabigatran etexilate mesylate	208040	EQ 150MG BASE	CAPSULE;ORAL
Alembic Pharms Ltd	dabigatran etexilate mesylate	208046	EQ 150MG BASE	CAPSULE;ORAL
Dr Reddys Labs Ltd	dabigatran etexilate mesylate	208048	EQ 150MG BASE	CAPSULE;ORAL
Glenmark Pharms Ltd	dabigatran etexilate mesylate	207984	EQ 110MG BASE	CAPSULE;ORAL
Hetero Labs Ltd Iii	dabigatran etexilate mesylate	207961	EQ 150MG BASE	CAPSULE;ORAL
>Applicant	>Generic Name	>NDA	>Strength	>Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

McKinsey

Moodys

Colorcon

Express Scripts

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.